Ausgabe 8/2019
Inhalt (32 Artikel)
Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia
Salwa Bakr, Mervat Khorshied, Noha Talha, Karim Yahia Jaffer, Nohair Soliman, Khaled Eid, Mona El-Ghamrawy
Colla corii asini might upregulate ZNF471 and THOC5 by KRAB domain–containing zinc-finger protein pathway and THO complex subunit 5 pathway to improve anemia of pregnant women with β-thalassemia
Yanfang Li, Zhanfeng Zhang, Lilin Yang, Xiangyi Li, Jingwen Zhou, Daocheng Li, Songping Luo
Association of alpha hemoglobin–stabilizing protein (AHSP) gene mutation and disease severity among HbE—beta thalassemia patients
Rudra Ray, Siddhesh Arun Kalantri, Sunistha Bhattacharjee, Ankita Biswas, Aiman Shahab, Sujana Biswas, Maitreyee Bhattacharyya
Establishing and evaluating an auto-verification system of thalassemia gene detection results
Xiaozhe Lin, Bizhen Cheng, Yingmu Cai, Xiaoyang Jiao, Xinran Yang, Qiaoxin Zhang, Yongni Wang
The abnormal function of CD39+ regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia
Yumeng Lu, Luya Cheng, Feng Li, Lili Ji, Xia Shao, Boting Wu, Yanxia Zhan, Chanjuan Liu, Zhihui Min, Yang Ke, Lihua Sun, Hao Chen, Yunfeng Cheng
In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies
Behnaz Pezeshkpoor, M. Gazorpak, A-C. Berkemeier, H. Singer, A. Pavlova, A. Biswas, J. Oldenburg
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients
P. Lamby, D. Wolff, S. Mielke, G. U. Grigoleit, P. Ljungman, I. Hilgendorf, E. Holler, B. Holler, D. Weber, W. Herr, D. Schiltz, S. Klein, S. Graf, V. Bjornhagen-Safwenberg, J. Dolderer, L. Prantl
Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation
Yu-Qian Sun, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Chen-Hua Yan, Zhao-Yu Liu, Xiao-Jun Huang
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice
Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese, Alessandra Iurlo, Mario Annunziata, Ester Maria Orlandi, Sara Galimberti, Gianni Binotto, Nicola Sgherza, Luigia Luciano, Bruno Martino, Antonella Russo Rossi, Massimiliano Bonifacio, Claudio Fozza, Malgorzata Monika Trawinska, Daniele Cattaneo, Chiara Elena, Claudia Baratè, Fiorenza De Gregorio, Matteo Molica, Giorgio La Nasa, Robin Foà, Massimo Breccia
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life
Matteo Molica, Gioia Colafigli, Emilia Scalzulli, Danilo Alunni Fegatelli, Sofia Chiatamone Ranieri, Lorenzo Rizzo, Daniela Diverio, Fabio Efficace, Roberto Latagliata, Robin Foà, Massimo Breccia
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
Nidhi Jyotsana, Amit Sharma, Anuhar Chaturvedi, Ramachandramouli Budida, Michaela Scherr, Florian Kuchenbauer, Robert Lindner, Fatih Noyan, Kurt-Wolfram Sühs, Martin Stangel, Denis Grote-Koska, Korbinian Brand, Hans-Peter Vornlocher, Matthias Eder, Felicitas Thol, Arnold Ganser, R. Keith Humphries, Euan Ramsay, Pieter Cullis, Michael Heuser
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice
Emilia Scalzulli, Matteo Molica, Danilo Alunni Fegatelli, Gioia Colafigli, Lorenzo Rizzo, Marco Mancini, Fabio Efficace, Roberto Latagliata, Robin Foà, Massimo Breccia
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study
Ron Ram, Odelia Amit, Tsila Zuckerman, Ronit Gurion, Pia Raanani, Yael Bar-On, Irit Avivi, Ofir Wolach
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis
Massimo Breccia, Luigiana Luciano, Novella Pugliese, Elena Rossi, Mario Tiribelli, Emilia Scalzulli, Massimiliano Bonifacio, Bruno Martino, Roberto Latagliata, Giulia Benevolo, Giovanni Caocci, Gianni Binotto, Vincenzo Martinelli, Michele Cavo, Fabrizio Pane, Valerio De Stefano, Robin Foà, Francesca Palandri
Clinical risk scores do not accurately identify a very high risk population with diffuse large B cell lymphoma—an analysis of 386 Portuguese patients
Rita Coutinho, J. Lobato, S. Esteves, J. Cabeçadas, M. Gomes da Silva
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin’s lymphoma
Francesco Gaudio, Claudia Nardelli, Paola Masciandaro, Tommasina Perrone, Filomena Emanuela Laddaga, Paola Curci, Raffaella Depalo, Ettore Cicinelli, Giorgina Specchia
Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy
Daniel Gutiérrez-Saborido, Alicia Gutiérrez-Valencia, Carmen María González Domenech, Miguel Ángel López Ruz, Miguel Raffo Márquez, Mohamed Omar, José Antonio Girón-González
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients
Andrea Janikova, Renata Chloupkova, Vit Campr, Pavel Klener, Jitka Hamouzova, David Belada, Vit Prochazka, Robert Pytlik, Jan Pirnos, Juraj Duras, Heidi Mocikova, Zbynek Bortlicek, Natasa Kopalova, Jiri Mayer, Marek Trneny
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Jérôme Cornillon, Elisabeth Daguenet, Jacques-Olivier Bay, Adrien Chauchet, Gilles Salles, Nathalie Contentin, Emmanuelle Nicolas-Virelizier, Mélanie Mercier, Nicolas Vallet, Magda Alexis, Marie-Lorraine Chrétien, Thomas Cluzeau, Anne Huynh, Chantal Himberlin, Véronique Dorvaux, Sandy Amorim, Caroline Lejeune, Régis Peffault de Latour, Emmanuel Gyan
Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan
Naoyo Ishikura, Yoshiaki Usui, Hidemi Ito, Yumiko Kasugai, Isao Oze, Seiichi Kato, Yasushi Yatabe, Shigeo Nakamura, Keitaro Matsuo
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report
Masaya Taniwaki, Shinya Katsutani, Masahiro Yamasaki, Kazuma Kawamoto, Kunihiko Funaishi, Yu Matsumoto, Naoko Matsumoto, Nobuyuki Ohashi, Noboru Hattori
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency
Christine Mouton, Lionel Leroux, Guillaume Bonnet, Benjamin Seguy, Aurélie Lafargue, Gildas Baulier, Sabine Castet, Mathieu Fiore
Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopenia
Emma P. DeLoughery, Aishwarya Ravindran, Aneel A. Ashrani, Kebede H. Begna, C. Christopher Hook, Ariela L. Marshall, Rajiv K. Pruthi, Alexandra P. Wolanskyj-Spinner, Ronald S. Go
Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman’s disease
Kazutoshi Ebisawa, Yosuke Masamoto, Junji Tokushige, Hiroshi Nishi, Kenjiro Honda, Munetoshi Hinata, Kazuhiro Toyama, Masaomi Nangaku, Mineo Kurokawa
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma
Ryo Nakagawa, Yasushi Onishi, Akihisa Kawajiri, Koichi Onodera, Eijiro Furukawa, Sayaka Sano, Kei Saito, Satoshi Ichikawa, Tohru Fujiwara, Noriko Fukuhara, Hideo Harigae
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus
Zhili Jin, Yini Wang, Jingshi Wang, Jia Zhang, Lin Wu, Zhao Wang
Clinicohematologic and cytogenetic profile in a rare case of pure erythroid leukemia
Smeeta Gajendra, Anil Kumar Yadav, Bhuvan Chugh, Nitin Sood, Manorama Bhargava
Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia
Hai Cheng, Xue Wang, Dian Zhou, Jiang Cao, Andre Larochelle, Kai-lin Xu
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
M. Blanes, J. I. Lorenzo, P. Ribas, A. Jiménez, J. D. González, M. J. Cejalvo, C. Solano, A. Alegre, Javier de la Rubia
Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma
Andrea Marra, Giovanni Martino, Stefano Ascani, Maria Paola Martelli, Brunangelo Falini
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
Marian Müller, Ricarda Graf, Karl Kashofer, Susanne Macher, Albert Wölfler, Armin Zebisch, Andelko Hrzenjak, Ellen Heitzer, Heinz Sill
Circulating cell-free DNA for response evaluation of intravascular lymphoma
Dries Deeren, Malaïka Van Der Linden, Franceska Dedeurwaerdere, Lien Deleu, Caressa Meert, Björn Menten, Jo Van Dorpe